Doublet vs. triplet regimen with newly diagnosed transplant- eligible multiple myeloma

Noriko Nishimura

Presentation information

Oral Session

Oral Session 1-10C MM: Proteasome inhibitors

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Michihide Tokuhira (Saitama Medical Center, Saitama Medical University, Japan)

[OS1-10C-5] Doublet vs. triplet regimen with newly diagnosed transplant- eligible multiple myeloma

Noriko Nishimura¹, Anna Nishihara¹, Norihito Inoue¹, Yoshiharu Kusano¹, Yuko Mishima¹, Masahiro Yokoyama¹, Kiyohiko Hatake², Yasuhito Terui¹ (1.Hematol./Oncol., The Cancer Institute Hospital of JFCR, 2.Hematol., International University of Health and Welfare, Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.